0.0624SEK-0.64%Mkt Cap: 173.45M SEKP/E: —Last update: 2026-05-13
Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small m…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.13
P/B3.13
P/S—
EV/EBITDA-2.35
EV/Revenue—
EPS (TTM)-0.02
EPS (Forward)0.00
Cash Flow & Leverage
FCF Yield-4.05%
FCF Margin—
Operating CF-32.40M SEK
CapEx (TTM)—
Net Debt/EBITDA1.76
Net Debt-63.36M SEK
Technical
SMA 500.0576 (+8.3%)
SMA 2000.0838 (-25.5%)
Beta1.33
S&P 52W Chg24.23%
Avg Vol (30d)41.29M
Avg Vol (10d)15.20M
Technical Indicators
RSI (14)52.3
MACD0.0004
MACD Signal0.0014
MACD Hist.-0.0010
BB Upper0.0756 SEK
BB Middle0.0648 SEK
BB Lower0.0539 SEK
BB Width33.54%
ATR (14)0.0062 SEK
Vol Ratio (20d)0.81x
52W Range
0.03708% of range0.3400
52W High0.3400 SEK
52W Low0.0370 SEK
Profitability
Gross Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
Oper. Margin0.00%
ROE-67.11%
ROA-53.16%
Revenue Growth—
Earnings Growth—
Balance Sheet
Debt/Equity0.03
Current Ratio4.67
Quick Ratio4.59
Book Value/Sh0.0210 SEK
Cash/Share0.0250 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.2.64B
Float2.05B
Insiders39.59%
Institutions10.37%
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)0.2500 SEK
Target Range0.2500 SEK – 0.2500 SEK
# Analysts1
Company
Market Cap173.45M SEK
Enterprise Value84.78M SEK
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-37.32M SEK
Revenue/Share—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees5
Last Price0.0624 SEK
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—